Published Date: 07 Mar 2023
The Delhi High Court, which rejected the city government's appeal, recently upheld a judge's order ordering the government to pay...
Read Full News1.
Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.
2.
If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version
3.
Older Adults With Advanced Cancer Prioritize Quality of Life
4.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
5.
Q&A: When will individuals be able to receive customized cancer vaccines?
1.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
2.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
3.
The Growing Challenge of Haematological Malignancies in Older Adults
4.
Understanding the HAS-BLED Score: What It Is and Why It Matters
5.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
2.
Navigating the Complexities of Ph Negative ALL - Part I
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
5.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation